期刊文献+

急性脑梗死患者血清C反应蛋白水平及他汀类药物对其作用的影响 被引量:9

Role of serum CRP in patients with cerebral infarction and the protection of statins
在线阅读 下载PDF
导出
摘要 目的探讨急性脑梗死患者血清C-反应蛋白(CRP)水平的变化,了解他汀类药物对血清CRP、血脂指标及患者预后的影响。方法随访观察急性脑梗死患者(包括60例他汀类治疗者,60例常规治疗者)及30例健康对照者,测定他汀类药物治疗前、治疗后2周血清CRP、血清总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)水平及NIHSS评分情况。结果急性脑梗死患者血清CRP水平高于对照组(P<0.01);血清CRP水平与入院时患者的NIHSS评分呈正相关(P<0.05);他汀组较常规组更能降低血清CRP以及血脂水平(P<0.01)。结论急性脑梗死患者血清CRP水平越高,病情越严重;他汀类药物具有降低血清CRP水平的作用,可能改善患者的预后。 Objective To investigate the changes of serum CRP and the effect of statins intervention on serum CRP levels, serum levels of total cholesterol(TC) , tfiglyceride(TG) , and low density cholesterol( LDL -C) as well as the outcome of cerebral infarction. Methods Participants were randomly derided into three groups:st- atins group(60 eases), blank group(60 eases) and healthy control group (30 cases). Serum CRP, TC, TG and LDL - C was tasted and National Institutes Health Stroke Seale (NIHSS) was examined from cerebral infarction patients at baseline and after treatment (2 weeks). Results Baseline serum CRP levels in cerebral infarction group were higher than that of control group( P 〈 0.01 ). Serum CRP levels had significant minus relation with NIHSS (P 〈 0.05). The decline of serum CRP, TC and LDL - C in statins group was more significant than those in blank group (P 〈 0.01 ). Conclusion Serum CRP levels increase in cerebral infarction patients. Higher serum CRP levels, worse pathogenetic condition. Statins may improve the outcome of cerebral infarction via affecting the serum CRP levels.
作者 刘恋 王为珍
出处 《海南医学》 CAS 2010年第15期12-14,共3页 Hainan Medical Journal
关键词 急性脑梗死 CRP 他汀类药物 Cerebral infarction CRP Statins
  • 相关文献

参考文献7

  • 1Shrive AK,Gheetham GM,Holden D,et al.Three dimensional structure of human C-reactive protein[J].Nature Struc Biol,1996,3(4):346-354.
  • 2Torzewki J,TorzewskiM,BovyerDE,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998,18(9):1 386-1 392.
  • 3Cermak J,Key NS,Bach RR,et al.C-reactive protein induceshuman peripheral blood monocytes to synthesize tissue factor[J].Blood,1993,82(2):513-520.
  • 4Cao JJ,Thach C,Manolio TA,et al.C-reactive protein,carotid intima-media thickness and incidence of ischemic stroke in the elderly:the CardiovascularHealth Study[J].Circulation,2003,108(2):166-170.
  • 5乔兴茂,王雷,姜文洲,郭广波,王信强.C反应蛋白与缺血性脑卒中的相关性研究[J].实用临床医学(江西),2005,6(3):20-21. 被引量:21
  • 6王文华.阿托伐他汀对急性脑梗死患者血脂和预后的影响[J].现代中西医结合杂志,2007,16(8):1020-1021. 被引量:6
  • 7曹红,孙长凯,赵杰,赵耿毅,唐树良,汪秋艳,侯宇,许晶,陶定波,刘新胜,黄爱莉.他汀类药物对脑梗死患者神经功能缺损及血清相关参数的影响[J].中国临床康复,2005,9(9):94-96. 被引量:25

二级参考文献21

  • 1赵水平,吴军,谭利明,胡治平,肖志杰,聂赛,周宏年,蒋波.他汀类药物对急性脑梗死的抗炎作用[J].中华医学杂志,2005,85(40):2841-2845. 被引量:48
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33091
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15780
  • 4Vaughan C J,Delanty N,Basson CT. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke? CNS Drugs 2001; 15:589 - 96.
  • 5Vaughan C J,Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30:1969 -73.
  • 6Sawada N,Itoh H,Nakao K. Novel actions of HMG-CoA reductase inhibitors(statins) -vascular and cerebral protection through inhibition of small GTPase Rho. Nippon Rinsho 2001;59:2470-5.
  • 7Delanty N,Vaughan C J,Sheehy N. Statins and neuroprotection. Expert Opin Investig Drugs 2001; 10:1847-53.
  • 8Vaughan CJ. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am J Cardiol 2003; 91: 23B - 29B.
  • 9Karaca I,Ilkay E,Akbulut M,et al. Atorvastatin affects C-reactive protein levels in patients with coronary artery disease. Curr Med Res Opin 2003; 19:187 - 91.
  • 10Lee KT,Lai WT,Chu CS,et al. Effect of withdrawal of statin on C-reactive protein. Cardiology 2004; 102:166 -70.

共引文献47

同被引文献59

  • 1凌莉,曾进胜.他汀类药物对缺血性卒中的脑保护作用[J].中国卒中杂志,2007,2(4):327-331. 被引量:9
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33091
  • 3柴福民,邱建东,阎彬彬,李呼伦,张定.大鼠脑缺血后IFN-γ mRNA的表达[J].中国实用医药,2006,1(1):2-5. 被引量:6
  • 4吴江.神经病学[M].北京:人民卫生出版社,2010:283.
  • 5Fujii Y. Retraction note: Management of postoperative nausea and vomiting in patients undergo- ing laparoscopic cholecystectomy[J]. Surg Endosc, 2011, 25(3) :691-695.
  • 6Poolsup N, Suksomboon N, Wongyaowarat K, et al. Meta-analysis of the comparative efficacy and safety of pitavas- tatin and atorvastatin in patients with dyslipidaemia[J]. J Clin Pharm Ther,2012,37(2) :166-172.
  • 7Ni Chroinin D, Callaly EL, Duggan J,et al. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke:the North Dublin Population Stroke Study [ J ]. Stroke,2011,42 (4) : 1021-1029.
  • 8Goldstein LB, Amarenco P, Zivin J, et al. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Choles- terol Levels (SPARCL) trial[ J]. Stroke,2009,40( 11 ) :3526-3531.
  • 9Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease : meta-analysis of indi- vidual data from 27 randomised trials [ J ]. Lancet, 2012,380 ( 984 ) : 581-590.
  • 10Prinz V, Endres M. Statins and stroke:prevention and beyond [ J ]. Curr Opin Neuro1,2011,24( 1 ) :75-80.

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部